Ann Raldow, MD, MPH
Specialty
Institutional Affiliation
Languages
Education
Internship
Degrees
Residency
Board Certification
Contact Information
Scientific Interests
Dr. Ann Raldow's research focuses on therapeutic decision making, cost-effective care, quality of life and health outcomes assessment.
Highlighted Publications
Raldow AC, Sher D, Chen AB, Recht A, Punglia RS. Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of Patients With Ductal Carcinoma In Situ. J Clin Oncol. 2016 Nov 20;34(33):3963-3968. doi: 10.1200/JCO.2016.67.8532. Epub 2016 Sep 30.
Raldow AC, Zhang D, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV. Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer. JAMA Oncol. 2015 Jun;1(3):334-40. doi: 10.1001/jamaoncol.2014.284.
Raldow AC, Zhang D, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV. Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy. Brachytherapy. 2015 Nov-Dec;14(6):781-7. doi: 10.1016/j.brachy.2015.08.004. Epub 2015 Sep 9.
Raldow AC, Brown JG, Chau N, Davids MS, Margalit, DN, Tishler RB, Ng A, Schoenfeld JD. Synchronous Squamous Cell Carcinoma and Diffuse Large B-cell Lymphoma of the Head and Neck: TheOddCouple. BJRCaseRep2015; 1:20150271.
Raldow AC, Chiang VL, Knisely JP, Yu JB. Survival and intracranial control of patients with 5 or more brain metastases treated with gamma knife stereotactic radiosurgery. Am J Clin Oncol. 2013 Oct;36(5):486-90. doi: 10.1097/COC.0b013e31825494ef.
